Reportedly last week a story that generated too much buzz was around the quality failure of many commonly used medicines. The trigger was the mention of widely used medications, including popular antacids, fever reducers, antibiotics and high-blood pressure medications in the monthly drug alert issued by the regulatory authority, Central drugs Standard Control Organization (CDSCO). After more than 24 hours, only two pharmaceutical companies shared the requested comments, while the others either ignored or did not acknowledge the email.
Previously on sunday morning, the indian Pharmaceutical Alliance (IPA) a pharma lobby backed by India’s top drug makers, some of whom were mentioned in the alert list issued a press release venting anger over unfair implications over legitimate drug makers in producing counterfeit drugs. It said that the lobby will collaborate with the government to strengthen regulations against counterfeit products to protect public health and India’s global standing.
Moreover Dr Anirvan Karmakar, senior consultant, critical care unit, Narayana Hospital, Howrah said that frequent drug failures erode patient trust in the healthcare system, making it harder for physicians to ensure compliance. “Physicians, too, need to remain vigilant and consider alternative treatments when drug quality concerns arise, ensuring that patient safety and effective treatment remain a priority."
click and follow Indiaherald WhatsApp channel